Sökning: onr:"swepub:oai:DiVA.org:umu-206769" > Detection of antinu...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08605naa a2200745 4500 | |
001 | oai:DiVA.org:umu-206769 | |
003 | SwePub | |
008 | 230426s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2067692 URI |
024 | 7 | a https://doi.org/10.1515/cclm-2023-02092 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Bonroy, Carolienu Department of Diagnostic Sciences, Ghent University, Ghent, Belgium; Department of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium4 aut |
245 | 1 0 | a Detection of antinuclear antibodies :b recommendations from EFLM, EASI and ICAP |
264 | c 2023-03-29 | |
264 | 1 | b Walter de Gruyter,c 2023 |
338 | a electronic2 rdacarrier | |
520 | a Objectives: Antinuclear antibodies (ANA) are important for the diagnosis of various autoimmune diseases. ANA are usually detected by indirect immunofluorescence assay (IFA) using HEp-2 cells (HEp-2 IFA). There are many variables influencing HEp-2 IFA results, such as subjective visual reading, serum screening dilution, substrate manufacturing, microscope components and conjugate. Newer developments on ANA testing that offer novel features adopted by some clinical laboratories include automated computer-assisted diagnosis (CAD) systems and solid phase assays (SPA).Methods: A group of experts reviewed current literature and established recommendations on methodological aspects of ANA testing. This process was supported by a two round Delphi exercise. International expert groups that participated in this initiative included (i) the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “Autoimmunity Testing”; (ii) the European Autoimmune Standardization Initiative (EASI); and (iii) the International Consensus on ANA Patterns (ICAP).Results: In total, 35 recommendations/statements related to (i) ANA testing and reporting by HEp-2 IFA; (ii) HEp-2 IFA methodological aspects including substrate/conjugate selection and the application of CAD systems; (iii) quality assurance; (iv) HEp-2 IFA validation/verification approaches and (v) SPA were formulated. Globally, 95% of all submitted scores in the final Delphi round were above 6 (moderately agree, agree or strongly agree) and 85% above 7 (agree and strongly agree), indicating strong international support for the proposed recommendations.Conclusions: These recommendations are an important step to achieve high quality ANA testing. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Immunologi inom det medicinska området0 (SwePub)301102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Immunology in the medical area0 (SwePub)301102 hsv//eng |
653 | a antinuclear antibodies | |
653 | a HEp-2 indirect immunofluorescence | |
653 | a recommendations | |
700 | 1 | a Vercammen, Martineu Department of Laboratory Medicine, AZ Sint-Jan, Brugge, Belgium; Research Group REIM, Vrije Universiteit Brussel, Brussels, Belgium4 aut |
700 | 1 | a Fierz, Walteru Schweizerischer Verband der Diagnostikindustrie (SVDI-ASID), Bern, Switzerland4 aut |
700 | 1 | a Andrade, Luis E.C.u Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Immunology Division, Fleury Medicine and Health Laboratories, Sao Paulo, Brazil4 aut |
700 | 1 | a Van Hoovels, Lieveu Department of Laboratory Medicine, OLV Hospital, Aalst, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium4 aut |
700 | 1 | a Infantino, Mariau Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Florence, Italy4 aut |
700 | 1 | a Fritzler, Marvin J.u Department of Medicine, Cumming School of Medicine, University of Calgary, AB, Calgary, Canada4 aut |
700 | 1 | a Bogdanos, Dimitriosu Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, University General Hospital of Larissa, Larissa, Greece4 aut |
700 | 1 | a Kozmar, Anau Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia4 aut |
700 | 1 | a Nespola, Benoitu Laboratory of Immunology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France4 aut |
700 | 1 | a Broeders, Sylviau Quality of Laboratories, Sciensano, Ixelles, Belgium4 aut |
700 | 1 | a Patel, Dinau UK NEQAS Immunology, Immunochemistry and Allergy, Sheffield Teaching Hospitals, Sheffield, United Kingdom4 aut |
700 | 1 | a Herold, Manfredu Department of Internal Medicine II, Rheumatology Laboratory, Medical University of Innsbruck, Innsbruck, Austria4 aut |
700 | 1 | a Zheng, Bingu Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China4 aut |
700 | 1 | a Chan, Eric Y.T.u Department of Pathology, Queen Mary Hospital, Hong Kong, Hong Kong4 aut |
700 | 1 | a Uibo, Raivou Department of Immunology, Medical Faculty, University of Tartu, Tartu, Estonia4 aut |
700 | 1 | a Haapala, Anna-Maijau Department of Immunology, Fimlab Laboratories, Tampere, Finland4 aut |
700 | 1 | a Musset, Lucileu Department of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France4 aut |
700 | 1 | a Sack, Ulrichu Medical Faculty, Leipzig University, Leipzig, Germany4 aut |
700 | 1 | a Nagy, Gaboru Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary4 aut |
700 | 1 | a Sundic, Tatjanau Department of Immunology and Transfusion Medicine, Haugesund Hospital, Helse Fonna, Haugesund, Norway4 aut |
700 | 1 | a Fischer, Katarzynau Individual Laboratory for Rheumatologic Diagnostics, Pomeranian Medical University in Szczecin, Szczecin, Poland4 aut |
700 | 1 | a Rego De Sousa, Maria-Joséu Immunopathology and Autoimmunity Department, Centro de Medicina Laboratorial Germano de Sousa, Lisbon, Portugal4 aut |
700 | 1 | a Vargas, Maria Luisau Immunology, Hospital Universitario de Badajoz, Badajoz, Spain4 aut |
700 | 1 | a Eriksson, Catharina,d 1955-u Umeå universitet,Institutionen för klinisk mikrobiologi4 aut0 (Swepub:umu)caaern74 |
700 | 1 | a Heijnen, Ingmaru Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland4 aut |
700 | 1 | a García-De La Torre, Ignaciou Department of Immunology and Rheumatology, Hospital General de Occidente, Universidad de Guadalajara, Guadalajara, Mexico4 aut |
700 | 1 | a Carballo, Orlando Gabrielu Laboratory of Immunology, Hospital Carlos G. Durand, Buenos Aires, Argentina; Department of Microbiology and Immunology, Instituto Universitario, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina4 aut |
700 | 1 | a Satoh, Minoruu Department of Human, Information and Life Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Medicine, Kitakyushu Yahata-Higashi Hospital, Kitakyushu, Japan4 aut |
700 | 1 | a Kim, Kyeong-Heeu Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, South Korea4 aut |
700 | 1 | a Chan, Edward K.L.u Department of Oral Biology, University of Florida, FL, Gainesville, United States4 aut |
700 | 1 | a Damoiseaux, Janu Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, Netherlands4 aut |
700 | 1 | a Lopez-Hoyos, Marcosu Immunology Service, University Hospital Marques de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain4 aut |
700 | 1 | a Bossuyt, Xavieru Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; Department of Laboratory Medicine, University Hospital Leuven, Leuven, Belgium4 aut |
710 | 2 | a Department of Diagnostic Sciences, Ghent University, Ghent, Belgium; Department of Laboratory Medicine, University Hospital Ghent, Ghent, Belgiumb Department of Laboratory Medicine, AZ Sint-Jan, Brugge, Belgium; Research Group REIM, Vrije Universiteit Brussel, Brussels, Belgium4 org |
773 | 0 | t Clinical Chemistry and Laboratory Medicined : Walter de Gruyterg 61:7, s. 1167-1198q 61:7<1167-1198x 1434-6621x 1437-4331 |
856 | 4 | u https://doi.org/10.1515/cclm-2023-0209y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1753344/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-206769 |
856 | 4 8 | u https://doi.org/10.1515/cclm-2023-0209 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy